MRNA Filing
4Filing Date: Jul 6, 2026

Moderna, Inc. (MRNA) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001682852-26-000129open_in_new
Total Value$51.0K
Trades3
Insiders1

Transaction Details

Mock James M
Chief Financial Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-703
Price$72.50
Total Value$51.0K
Shares Owned After66.44K
Transaction DateJul 2, 2026
Footnotes ▸

Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.

Mock James M
Chief Financial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.45K
Price-
Total Value$0
Shares Owned After67.14K
Transaction DateJul 2, 2026
Footnotes ▸

Restricted stock units convert into common stock on a one-for-one basis. | Restricted stock units convert into common stock on a one-for-one basis.

Mock James M
Chief Financial Officer·Direct
Exercise · Dispose
Restricted Stock UnitsDerivative
Shares-1.45K
Price$0.00
Total Value$0
Shares Owned After1.45K
Transaction DateJul 2, 2026
Footnotes ▸

Restricted stock units convert into common stock on a one-for-one basis. | Restricted stock units convert into common stock on a one-for-one basis. | 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. | 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Post-Transaction Holdings

Mock James M
SecuritySharesChange
Common Stock66.44K+749 (1.14%)
Restricted Stock Units1.45K-1.45K (-49.97%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-02 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Mock James M CIK: 0001736359 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-02 | Code: M (Exercise of derivative) Shares: +1,452 Shares Owned After: 67,139 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [Transaction #2] Security: Common Stock Date: 2026-07-02 | Code: F (Payment of exercise/tax) Shares: -703 | Price: $72.50 Total Value: $50,967.50 Shares Owned After: 66,436 | Ownership: D (Direct) Footnotes: [F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-07-02 | Code: M (Exercise of derivative) Shares: -1,452 | Price: $0.00 Shares Owned After: 1,454 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [F3] 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [F3] 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Footnotes (Complete Index) --- F1: Restricted stock units convert into common stock on a one-for-one basis. F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3: 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Signature --- /s/ /s/ James Dillon, As Attorney-in-Fact (2026-07-06)

keid AI analysis is for reference only and does not constitute investment advice.